Lista de obras -

Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors

artículo científico publicado en 2018

Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids

scientific article published on 20 November 2019

Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

artículo científico publicado en 2014

Bioactivation potential of thiophene-containing drugs.

artículo científico

Bisphenol A and its analogs: Do their metabolites have endocrine activity?

artículo científico publicado en 2016

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling

scientific article published on 17 December 2018

Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.

artículo científico publicado en 2017

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10

artículo científico publicado en 2014

Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors

artículo científico publicado en 2016

Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase

artículo científico publicado en 2010

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

artículo científico publicado en 2019

Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays

artículo científico publicado en 2018

Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids

artículo científico publicado en 2016

Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin

artículo científico publicado en 2014

MurD enzymes from different bacteria: Evaluation of inhibitors

artículo científico publicado en 2012

Mutagenicity and DNA damage of bisphenol A and its structural analogues in HepG2 cells.

artículo científico publicado en 2013

N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation

artículo científico publicado en 2015

New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors

artículo científico publicado en 2019

New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity

artículo científico publicado en 2018

New brominated flame retardants and their metabolites as activators of the pregnane X receptor.

artículo científico publicado en 2016

Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies

artículo científico publicado en 2006

Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics

artículo científico publicado en 2003

Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.

artículo científico publicado en 2004

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes

scientific article published on 10 July 2018

Rational design of balanced dual-targeting antibiotics with limited resistance

scientific article published on 05 October 2020

Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.

artículo científico publicado en 2005

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

artículo científico publicado en 2012

Selective 3-amino-2-pyridinone acetamide thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1-arginine mimetics

artículo científico publicado en 2003

Lista de obras de

Analogues of the Lignan Pinoresinol as Novel Lead Compounds for P-glycoprotein (P-gp) Inhibitors

Applicability of the OECD 455 in-vitro assay for determination of hERa agonistic activity of isoflavonoids

Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

Bioactivation potential of thiophene-containing drugs.

Bisphenol A and its analogs: Do their metabolites have endocrine activity?

Data on biosynthesis of BPAF glucuronide, enzyme kinetics of BPAF glucuronidation, and molecular modeling

Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors.

Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10

Discovery of Benzothiazole Scaffold-Based DNA Gyrase B Inhibitors

Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase

Efflux pump inhibitors of clinically relevant multidrug resistant bacteria

Evaluation of endocrine activities of ellagic acid and urolithins using reporter gene assays

Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids

Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin

MurD enzymes from different bacteria: Evaluation of inhibitors

Mutagenicity and DNA damage of bisphenol A and its structural analogues in HepG2 cells.

N-Phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATP Competitive DNA Gyrase B Inhibitors: Design, Synthesis, and Evaluation

New N-phenyl-4,5-dibromopyrrolamides as DNA gyrase B inhibitors

New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity

New brominated flame retardants and their metabolites as activators of the pregnane X receptor.

Novel agents aiming at specific molecular targets increase chemosensitivity and overcome chemoresistance in hematopoietic malignancies

Novel thrombin inhibitors incorporating non-basic partially saturated heterobicyclic P1-arginine mimetics

Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.

Physiologically Based Pharmacokinetic (PBPK) Modeling of the Bisphenols BPA, BPS, BPF, and BPAF with New Experimental Metabolic Parameters: Comparing the Pharmacokinetic Behavior of BPA with Its Substitutes

Rational design of balanced dual-targeting antibiotics with limited resistance

Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

Selective 3-amino-2-pyridinone acetamide thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1-arginine mimetics